Cart
sales@molnova.com
Anavenol
CAS No. 93-20-9
Anavenol( 2-(naphthalen-2-yloxy)ethanol )
Catalog No. M27187 CAS No. 93-20-9
Anavenol is an equine anesthetic.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 31 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 73 | In Stock |
|
| 100MG | 110 | In Stock |
|
| 200MG | 163 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAnavenol
-
NoteResearch use only, not for human use.
-
Brief DescriptionAnavenol is an equine anesthetic.
-
DescriptionAnavenol is an equine anesthetic.
-
In Vitro——
-
In Vivo——
-
Synonyms2-(naphthalen-2-yloxy)ethanol
-
PathwayOthers
-
TargetOther Targets
-
RecptorEGFR| ErbB2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number93-20-9
-
Formula Weight188.226
-
Molecular FormulaC12H12O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCOc1ccc2ccccc2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kwak EL, et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7665-70.
molnova catalog
related products
-
Pulsatilla saponin D
Pulsatilla saponin D has exhibited potential beneficial effects as a chemopreventive agent for critical health conditions including cancer and it inhibits cell growth via cell cycle arrest and apoptosis in various cancer cell types.
-
NY-BR-1 p904 A2
T-cell clones specific for this NY-BR-1 epitope (p904) can recognize breast tumor cells expressing NY-BR-1.
-
Antagonist G
Antagonist G is a potent vasopressin antagonist. Antagonist G is also a weak antagonist of GRP and Bradykinin. Antagonist G induces AP-1 transcription and sensitizes cells to chemotherapy.
